Ligation Devices Market - By Product (Instruments, Accessories), By Procedure Type (MIS, Open Surgery), By Application (Gastrointestinal & Abdominal Surgery), By End-use & Forecast, 2023 – 2032

Ligation Devices Market Size

Ligation Devices Market size was valued at around USD 1 billion in 2022 and is projected to reach over USD 1.8 billion by 2032. This is driven by rising number of gastrointestinal, gynecological, urological, and cardiac surgery procedures.
 

For instance, according to the National Centers of Biotechnology Information (NCBI), in 2018, around 9.6 million inpatient procedures were conducted and approximately 11.2% were minimally invasive, indicating a considerable increase in the recent years. The growing demand for ligation devices for the treatment of gastrointestinal, gynecological, urological, and cardiac surgeries is further set to propel the business growth.
 

Also, the prevalence of age-related diseases and the increasing need for endoscopic procedures that require ligation devices are further accelerating the market growth. Additionally, technological advancements and product launches in the ligation devices business space are anticipated to propel the industry growth.
 

Ligation devices are medical devices used to ligate or tie off blood vessels, ducts, or other tubular structures during surgical procedures. These devices are commonly used in a variety of surgeries, including gastrointestinal, gynecological, urological, and cardiac surgeries, to control bleeding and to close off vessels or other structures. Ligation devices are also used in minimally invasive procedures, such as endoscopic surgeries that require small incisions and specialized equipment to perform. These devices may come in different forms, such as clips, bands, or sutures, and are designed to be safe and effective in controlling bleeding and other surgical complications.
 

The high cost of ligation devices may negatively impact the market expansion, as it may limit the affordability and accessibility of these devices for some patients & healthcare providers, especially in the emerging economies. While ligation devices are considered essential medical devices in many surgical procedures, the high cost of these devices may make them prohibitively expensive for some healthcare facilities and patients.
 

In addition, the cost of ligation devices may also be a barrier to market development, as healthcare providers may opt for lower-cost alternatives that could limit the demand for these devices. Moreover, certain potential complications associated with the use of these devices might impede the market revenue progression. Certain commonly observed complications associated with the use of ligation devices include bleeding, infection, tissue damage, allergic reactions, and device failure.
 

COVID-19 Impact

The recent outbreak of COVID-19 had negatively influenced the ligation devices market revenue surge, specifically during the first half of 2020. The incremental demand for COVID-19 testing has had a significant impact on the surgical services and reduced the procedural volume that hampered the product adoption. Due to the risk of infection, many patients postponed endoscopic procedures along with other medical procedures.
 

Additionally, movement restrictions and disruptions in the supply chain have led to challenges in product distribution, further impacting the revenue of several industry players in fiscal year 2020. The developments, majorly defined by the reduced procedural volume negatively hampered the market growth in 2020. However, the reduced incidence of COVID-19 cases and collaborated efforts undertaken by major players are set to benefit the market progress.
 

Ligation Devices Market Trends

Increasing preference for minimally invasive procedures is anticipated to proliferate the industry outlook. In minimally invasive procedures, healthcare professionals use a broad range of techniques to perform surgical procedures with minimal damage to the patient’s body, in comparison with the conventional surgery approach. Usually, a minimally invasive surgery is related with less postoperative pain, shorter duration of hospital stays, and less blood loss. An additional benefit for growing preference of minimally invasive surgeries presents lower probability of infection and surgical complications as compared to invasive procedure. As a result, the patient demand for minimally invasive surgery is rising due to the benefits such as reduced risk, smaller incisions, less pain, and faster recovery process.
 

Moreover, ongoing developments have favoured the evolution of surgical procedures that incorporate ligation devices and are associated with a less invasive nature in the treatment of related ailments. Also, the rising preference and awareness pertaining to minimally invasive procedures among the exponentially growing geriatric population is expected to augment the market progression.
 

Ligation Devices Market Analysis

Based on product, the ligation devices market is segmented as instruments and accessories. The accessories segment accounted for highest revenue share of over 56% and is anticipated to progress at a rapid pace during the analysis timeframe period. The accessories include a broad range of equipment such as applicators, cartridges, and reloads that are used in conjunction with ligation devices to facilitate surgical procedures. As the demand for ligation devices continues to rise, the accessories segment is expected to grow alongside it. This growth is mainly driven by factors such as the increasing number of surgical procedures, the growing demand for minimally invasive surgeries, and the rising prevalence of age-related diseases.
 

Based on procedure type, the ligation devices market is segmented as minimally invasive surgery and open surgery. The minimally invasive surgery segment projected to grow at fastest 6.2% CAGR from 2023-2032. This is attributed to several factors, including an increase in gastrointestinal and abdominal procedures and the growing popularity of minimally invasive surgeries (MIS). Compared to traditional open surgeries, MIS procedures offer numerous benefits such as reduced incisions, lower risk of complications, quicker recovery times, less scarring, and improved patient outcomes. As a result, these surgeries have gained widespread recognition in the medical community.
 

Based on application, the ligation devices market is segmented as gastrointestinal & abdominal surgery, gynecological surgery, cardiothoracic surgery, urological surgery, and others. The gastrointestinal & abdominal surgery segment accounted for the highest market share in 2022 and is anticipated to reach more than USD 689 million by 2032. The rising number of gastrointestinal and abdominal surgeries is driving demand for ligation devices that are commonly used in these procedures.
 

According to the Journal of Gastrointestinal Surgery, published in 2021, the study conducted by the American Board of Surgery to identify trends in abdominal surgery highlighted a steady increase in the number of laparoscopic procedures performed. Further, this study also revealed that minimally invasive surgery is increasingly preferred across a range of surgical specialties. As these surgeries become more common, the demand for ligation devices is expected to surge.  
 

Based on end-use, the ligation devices market is segmented as hospitals, ambulatory surgical centers, and others. The hospital segment was valued at over USD 690 million in 2022. This is majorly attributed to the increasing patient influx for endoscopic procedures, availability of advanced equipment, better medical accessibility, and the high volume of surgeries. As the hospital facilities seek to improve patient outcomes and reduce post-operative complications, the demand for ligation devices that are safe, effective, and easy to use is expected to increase. Additionally, as more hospitals adopt minimally invasive surgical techniques, the demand for ligation devices that are specifically designed for these procedures is further set to prove conducive for the market growth.
 

U.S. ligation devices market is projected to reach more than USD 655 million by 2032. This high revenue surge is primarily pertaining to multiple factors including the rapidly aging population, rising preference for minimally invasive surgeries, and the increasing prevalence of abdominal ailments. For instance, as per the National Institute of Diabetes and Digestive & Kidney Diseases (NIDDK) in 2019, 60 to 70 million people were affected by digestive diseases that lead to more than 48 million ambulatory visits in the U.S. Further, approximately 5.4 million undergo diagnostic & therapeutic procedures and these medical procedures employ ligation devices. These statistics highlight that the rising patient pool is directly proportional to the ligation devices adoption.
 

Also, the GI & abdominal surgeries are on the rise. As per the National Endoscopy Database/Clinical Outcomes Research Initiative, in 2019, it is estimated that more than 20 million GI endoscopies are every year in the U.S. The other variables propelling the business growth include the presence of key market players, established healthcare facilities, supportive government initiatives, and a notable rise in the number of research collaborations.
 

Ligation Devices Industry Leaders

Some of the major players operating in the ligation devices market are:

• Medtronic Plc
• Johnson and Johnson (Ethicon)
• Cooper Surgical (the Cooper Companies, Inc.)
• CONMED Corporation
• B Braun Melsungen AG,
• Teleflex Incorporated
   

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.
 

Ligation Devices Industry News:

• In June 2021, Johnson & Johnson Medical Devices Companies announced the launch of the ECHELON CIRCULAR Powered Stapler with Tri-Staple technology that includes a ligation device, for use in colorectal, gastric, and thoracic surgical procedures. This launch helped the company to introduce innovative products, further offering a competitive edge.
   
• In December 2020, ConMed Corporation announced a collaboration with PhyzioTech, Inc. to develop and commercialize a suite of minimally invasive surgical tools, including ligation devices, for the treatment of pelvic floor disorders. This product launch helped the company to strengthen its product portfolio across the market.
   

 Ligation devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million & Units)

• Instruments
• Accessories

By Procedure Type, 2018 - 2032 (USD Million)

• Minimally Invasive Surgery
• Open Surgery

By Application, 2018 - 2032 (USD Million)

• Gastrointestinal and Abdominal Surgery
• Gynecological Surgery
• Cardiothoracic Surgery
• Urological Surgery
• Others

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Ambulatory Surgical Centers
• Others  

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Switzerland
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Turkey